June 12, 2009
Very soon, FDA will restart its End of Phase 2a (EOP2a) meeting program during which sponsors and FDA collaborate often using modeling and simulation to analyze current data, refine clinical trial design, and to inform industry’s critical go/no-go decisions on projects.
April 14, 2009
Ted Grasela, president and CEO of Cognigen Corporation, presented The Changing Drug Development Paradigm and Implications for Pharmacoepidemiology at Yale University on April 9, 2009.
March 26, 2009
March 25, 2009
March 24, 2009
When Cognigen wanted to redesign its website, we partnered with a local Buffalo company - Crowley Webb and Associates. We wanted an innovative, non-traditional website that everyone would take an interest in. Here it is!
November 17, 2008
The American Association of Pharmaceutical Scientists (AAPS), at its 2008 Annual Meeting held in Atlanta, Georgia, named Ted Grasela, PharmD, PhD, a 2008 AAPS Fellow. Dr. Grasela was nominated and selected for this prestigious award based on more than 20 years of sustained remarkable scholarly and research contributions to the pharmaceutical sciences in modeling and simulation.